The burden of headache and a health-care needs assessment in the adult population of Mali: a cross-sectional population-based study.


Journal

The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 20 05 2024
accepted: 12 06 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Our recent studies have shown headache disorders to be very common in the central and western sub-Saharan countries of Benin and Cameroon. Here we report headache in nearby Mali, a strife-torn country that differs topographically, culturally, politically and economically. The purposes were to estimate headache-attributed burden and need for headache care. We used cluster-random sampling in seven of Mali's eleven regions to obtain a nationally representative sample. During unannounced household visits by trained interviewers, one randomly selected adult member (18-65 years) from each household was interviewed using the structured HARDSHIP questionnaire, with enquiries into headache in the last year and, additionally, headache yesterday (HY). Headache on ≥ 15 days/month (H15+) was diagnosed as probable medication-overuse headache (pMOH) when associated with acute medication use on ≥ 15 days/month, and as "other H15+" when not. Episodic headache (on < 15 days/month) was recorded as such and not further diagnosed. Burden was assessed as impaired participation (days lost from paid and household work, and from leisure activity). Need for headache care was defined by criteria for expectation of benefit. Data collection coincided with the SARS-CoV-2 pandemic. The participating proportion was nonetheless extremely high (99.4%). The observed 1-year prevalence of any headache was 90.9%. Age- and gender-adjusted estimates were 86.3% for episodic headache, 1.4% for pMOH and 3.1% for other H15+. HY was reported by 16.8% with a mean duration of 8.7 h. Overall mean headache frequency was 3.5 days/month. Participants with pMOH lost more days from paid (8.8 days/3 months) and household work (10.3 days/3 months) than those with other H15+ (3.1 and 2.8 days/3 months) or episodic headache (1.2 and 0.9 days/3 months). At population level, 3.6-5.8% of all time was spent with headache, which led to a 3.6% decrease in all activity (impaired participation). Almost a quarter (23.4%) of Mali's adult population need headache care. Headache is very common in Mali, as in its near neighbours, Benin and Cameroon, and associated with substantial losses of health and productivity. Need for headache care is high - a challenge for a low-income country - but lost productivity probably translates into lost gross domestic product.

Sections du résumé

BACKGROUND BACKGROUND
Our recent studies have shown headache disorders to be very common in the central and western sub-Saharan countries of Benin and Cameroon. Here we report headache in nearby Mali, a strife-torn country that differs topographically, culturally, politically and economically. The purposes were to estimate headache-attributed burden and need for headache care.
METHODS METHODS
We used cluster-random sampling in seven of Mali's eleven regions to obtain a nationally representative sample. During unannounced household visits by trained interviewers, one randomly selected adult member (18-65 years) from each household was interviewed using the structured HARDSHIP questionnaire, with enquiries into headache in the last year and, additionally, headache yesterday (HY). Headache on ≥ 15 days/month (H15+) was diagnosed as probable medication-overuse headache (pMOH) when associated with acute medication use on ≥ 15 days/month, and as "other H15+" when not. Episodic headache (on < 15 days/month) was recorded as such and not further diagnosed. Burden was assessed as impaired participation (days lost from paid and household work, and from leisure activity). Need for headache care was defined by criteria for expectation of benefit.
RESULTS RESULTS
Data collection coincided with the SARS-CoV-2 pandemic. The participating proportion was nonetheless extremely high (99.4%). The observed 1-year prevalence of any headache was 90.9%. Age- and gender-adjusted estimates were 86.3% for episodic headache, 1.4% for pMOH and 3.1% for other H15+. HY was reported by 16.8% with a mean duration of 8.7 h. Overall mean headache frequency was 3.5 days/month. Participants with pMOH lost more days from paid (8.8 days/3 months) and household work (10.3 days/3 months) than those with other H15+ (3.1 and 2.8 days/3 months) or episodic headache (1.2 and 0.9 days/3 months). At population level, 3.6-5.8% of all time was spent with headache, which led to a 3.6% decrease in all activity (impaired participation). Almost a quarter (23.4%) of Mali's adult population need headache care.
CONCLUSION CONCLUSIONS
Headache is very common in Mali, as in its near neighbours, Benin and Cameroon, and associated with substantial losses of health and productivity. Need for headache care is high - a challenge for a low-income country - but lost productivity probably translates into lost gross domestic product.

Identifiants

pubmed: 38937699
doi: 10.1186/s10194-024-01811-5
pii: 10.1186/s10194-024-01811-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Informations de copyright

© 2024. The Author(s).

Références

Adoukonou T, Agbetou M, Dettin E, Kossi O, Husøy A, Thomas H, Houinato D, Steiner TJ (2004) The prevalence and demographic associations of headache in the adult population of Benin: a cross-sectional population-based study. J Headache Pain 2024; 25: 52
Kuate Tegueu C, Dzudie Tamdja A, Kom F, Forgwa Barche B, Ebasone P, Magnerou M et al (2024) Headache in the adult population of Cameroon: prevalence estimates and demographic associations from a cross-sectional nationwide population-based study. J Headache Pain 25:42. https://doi.org/10.1186/s10194-024-01748-9
doi: 10.1186/s10194-024-01748-9 pubmed: 38515027 pmcid: 10956204
Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23:34. https://doi.org/10.1186/s10194-022-01402-2
doi: 10.1186/s10194-022-01402-2 pubmed: 35410119 pmcid: 9004186
Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19:109–117. https://doi.org/10.1038/s41582-022-00763-1
doi: 10.1038/s41582-022-00763-1 pubmed: 36693999
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M et al (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396:1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
doi: 10.1016/S0140-6736(20)30925-9
World Bank Country and Lending Groups https://datahelpdesk.worldbank.org/knowledgebase/articles/906519 . Accessed August 10th 2023
The world factbook Mali. https://www.cia.gov/the-world-factbook/countries/mali/ . Accessed August 9th 2023
Mali (2023) https://en.wikipedia.org/wiki/Mali
Mali Population (2023) https://worldpopulationreview.com/countries/mali-population . Accessed August 9th 2023
The World Bank in Mali https://www.worldbank.org/en/country/mali/overview . Accessed August 9th 2023
Poorest Countries in the World https://wisevoter.com/country-rankings/poorest-countries-in-the-world/ . Accessed August 9th 2023
Poorest countries in the world 2023 https://worldpopulationreview.com/country-rankings/poorest-countries-in-the-world . Accessed August 9th 2023
World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for Medical Research Involving human subjects. JAMA 310:2191–2194. https://doi.org/10.1001/jama.2013.281053
doi: 10.1001/jama.2013.281053
Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsarava Z et al (2014) The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the global campaign against Headache. J Headache Pain 15:5. https://doi.org/10.1186/1129-2377-15-5
doi: 10.1186/1129-2377-15-5 pubmed: 24467862 pmcid: 3907133
Steiner TJ, Gururaj G, Andrée C, Katsarava Z, Ayzenberg I, Yu SY et al (2014) Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain 15:3. https://doi.org/10.1186/1129-2377-15-3
doi: 10.1186/1129-2377-15-3 pubmed: 24400999 pmcid: 3906903
Steiner TJ, Lipton RB (2018) The headache-attributed Lost Time (HALT) indices: measures of burden for clinical management and population-based research. J Headache Pain 19:12. https://doi.org/10.1186/s10194-018-0837-3
doi: 10.1186/s10194-018-0837-3 pubmed: 29396646 pmcid: 5796955
The WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28:551–558. https://doi.org/10.1017/s0033291798006667
doi: 10.1017/s0033291798006667
Sampaio Rocha-Filho PA (2022) Headache associated with COVID-19: epidemiology, characteristics, pathophysiology, and management. Headache 62:650–656. https://doi.org/10.1111/head.14319
doi: 10.1111/head.14319 pubmed: 35545780 pmcid: 9348060
Westergaard ML, Munksgaard SB, Bendtsen L, Jensen RH (2016) Medication-overuse headache: a perspective review. Ther Adv Drug Saf 7:147–158. https://doi.org/10.1177/2042098616653390
doi: 10.1177/2042098616653390 pubmed: 27493718 pmcid: 4959634
Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C et al (2023) Medication overuse headache. Nat Rev Dis Primers 9:5. https://doi.org/10.1038/s41572-022-00415-0
doi: 10.1038/s41572-022-00415-0 pubmed: 36732518
Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf 5:87–99. https://doi.org/10.1177/2042098614522683
doi: 10.1177/2042098614522683 pubmed: 25083264 pmcid: 4110872
Tackling malaria in Mali through stronger surveillance (2023) https://www.afro.who.int/countries/mali/news/tackling-malaria-mali-through-stronger-surveillance
World Health Organization Lifting the Burden (2011) Atlas of headache disorders and resources in the world, 2011. Geneva: World Health Organization
Tinelli M, Leonardi M, Paemeleire K, Raggi A, Mitsikostas D, de la Ruiz E, Steiner TJ (2021) Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain 22:90
doi: 10.1186/s10194-021-01305-8 pubmed: 34380429 pmcid: 8359596

Auteurs

Youssoufa Maiga (Y)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Seybou H Diallo (SH)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.
Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Oumar Sangho (O)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Leon Samuel Moskatel (LS)

Department of Neurology, Stanford University, Palo Alto, CA, USA.

Fatoumata Konipo (F)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Abdoulaye Bocoum (A)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Salimata Diallo (S)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Awa Coulibaly (A)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Mariam Daou (M)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Housseini Dolo (H)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Modibo Sangaré (M)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Mohamed Albakaye (M)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Zoumana Traoré (Z)

Medicine Unit, Hospital of Mali, Bamako, Mali.

Thomas Coulibaly (T)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Adama Sissoko (A)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Guida Landouré (G)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Boubacar Guindo (B)

Faculty of Medicine, University of Technical Sciences and Technologies, Bamako, Mali.

Mahamoudou Ahamadou (M)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Mahamane Drahamane Toure (MD)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Abibatou Dembele (A)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Habib Sacko (H)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Cheick Abdoul Kadri Sao (CA)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Diakalia Coulibaly (D)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Salimata Dembele (S)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Cheick Oumar Coulibaly (CO)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Mohamadou Sanogo (M)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Sekou Boiguilé (S)

Department of Neurology, Gabriel Touré Teaching Hospital, Bamako, Mali.

Julien Nizard (J)

Faculty of Medicine, University of Nantes, Nantes, France.

Robert Cowan (R)

Department of Neurology, Stanford University, Palo Alto, CA, USA.

Timothy J Steiner (TJ)

NorHEAD,Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Edvard Griegs gate, Trondheim, Norway.
Department of Neurology, University of Copenhagen, Copenhagen, Denmark.
Division of Brain Sciences, Imperial College London, London, UK.

And Andreas Husøy (AA)

NorHEAD,Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Edvard Griegs gate, Trondheim, Norway. ahusoy@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH